100 Active Studies

Multiple Sclerosis Clinical Trials

Find actively recruiting research studies for multiple sclerosis. Connect with study sites near you and explore new treatment options.

100
Active Trials
309+
Locations
115,090
Participants Needed

Recruiting Studies

RecruitingNCT01656603

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems....

10 locations(Birmingham, Phoenix, Phoenix)
9,999 participants
New York Blood Center
View Study Details
RecruitingNCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood vessel problems....

10 locations(Phoenix, Tucson, Little Rock)
7,410 participants
VA Office of Research and Development
View Study Details
RecruitingNCT06424288

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more...

10 locations(Mobile, Mobile, Chula Vista)
6,000 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascu...

10 locations(Dothan, Fairhope, Huntsville)
5,056 participants
Amgen
View Study Details
RecruitingNCT02693535

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or ...

10 locations(Birmingham, Phoenix, Auburn)
4,200 participants
American Society of Clinical Oncology
View Study Details
RecruitingNCT06076304

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis

Sinus infections are sometimes treated with oral antibiotics or nasal steroid sprays, while some patients get better on their own. Some patients may wait a few days or use common over-the-counter reme...

7 locations(Los Angeles, Washington D.C., Hyattsville)
3,720 participants
Daniel Merenstein
View Study Details
RecruitingNCT06667700

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. However, people with certain health condition...

10 locations(Cullman, Paradise Valley, Phoenix)
3,082 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06372145

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or NRSPMS who were previou...

10 locations(Birmingham, Cullman, Phoenix)
2,500 participants
Sanofi
View Study Details
RecruitingNCT06824194

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneumococcal vaccine) compared to a licensed 20-valent ...

10 locations(Guntersville, Jonesboro, Concord)
2,320 participants
Sanofi
View Study Details
RecruitingNCT05485961

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a dose-finding study for CSL300 vs placebo. Part 2 (pha...

10 locations(Huntsville, Montgomery, Glendale)
2,310 participants
CSL Behring
View Study Details
RecruitingNCT04373564

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the orga...

10 locations(Scottsdale, New Haven, Chicago)
2,076 participants
Guerbet
View Study Details
RecruitingNCT05564390

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical tria...

10 locations(Birmingham, Phoenix, Tucson)
2,000 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT06238622

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medic...

10 locations(Birmingham, Tucson, Los Angeles)
1,700 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT05047172

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracer...

10 locations(Birmingham, Mobile, Phoenix)
1,683 participants
University of Florida
View Study Details
RecruitingNCT06846541

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to answer are: * How safe is taking ESK-001 long-ter...

10 locations(Birmingham, Chandler, Pheonix)
1,680 participants
Alumis Inc
View Study Details
RecruitingNCT06401330

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in chi...

10 locations(Birmingham, Anchorage, Mesa)
1,656 participants
Children's Oncology Group
View Study Details
RecruitingNCT06736041

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is safe and can help the body to develop g...

10 locations(Tucson, Fayetteville, Huntington Park)
1,630 participants
Sanofi Pasteur, a Sanofi Company
View Study Details
RecruitingNCT06141473

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of teriflunomide in male and female participants...

10 locations(Birmingham, Cullman, Homewood)
1,600 participants
Sanofi
View Study Details
RecruitingNCT05352672

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN2810, also known as cemiplimab (each individually call...

10 locations(La Jolla, Los Angeles, Miami)
1,535 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNCT06324318

Parenting in 2 Worlds Multisite Trial

This research study will test the effectiveness of a culturally grounded parenting intervention called Parenting in 2 Worlds (P2W). This intervention is designed for American Indian / Alaska Native (A...

4 locations(Phoenix, Denver, Saint Paul)
1,440 participants
Arizona State University
View Study Details
RecruitingNCT06653153

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study ...

10 locations(Birmingham, Chandler, Mesa)
1,400 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04474223

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Fetal complete (i.e., third degree, 3°) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally associated with mate...

10 locations(Phoenix, Los Angeles, Palo Alto)
1,300 participants
NYU Langone Health
View Study Details
RecruitingNCT06468228

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under ar...

10 locations(Birmingham, Phoenix, Tucson)
1,280 participants
AbbVie
View Study Details
RecruitingNCT06061861

Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study

The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (...

2 locations(Pasadena, Pleasanton)
1,100 participants
Kaiser Permanente
View Study Details
RecruitingNCT06025578

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis....

10 locations(Birmingham, Phoenix, Phoenix)
1,092 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT05134441

Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-1)...

10 locations(Phoenix, Bradenton, Miami)
1,050 participants
Immunic AG
View Study Details
RecruitingNCT05201638

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2)...

10 locations(Scottsdale, Altamonte Springs, Coral Springs)
1,050 participants
Immunic AG
View Study Details
RecruitingNCT05843643

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how safe and effective upadacitinib is in treating adult...

10 locations(Chandler, Flagstaff, Gilbert)
1,000 participants
AbbVie
View Study Details
RecruitingNCT06764485

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate Cancer....

10 locations(Birmingham, Gilbert, Anaheim)
960 participants
Celgene
View Study Details
RecruitingNCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from pati...

10 locations(Birmingham, Mobile, Anchorage)
960 participants
PedAL BCU, LLC
View Study Details
RecruitingNCT04895709

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab or docetaxel in participants with advanced solid...

10 locations(Clovis, Los Angeles, Newport Beach)
949 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT06855160

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

This study aims to assess the immune response and safety of GSK's candidate chickenpox and marketed MMR vaccines when given to children 12 to 15 months of age via a muscle injection. It compares the G...

6 locations(Tucson, Huntington Park, Sherman Oaks)
900 participants
GlaxoSmithKline
View Study Details
RecruitingNCT06141486

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to 36 months ...

10 locations(Homewood, Phoenix, Scottsdale)
900 participants
Sanofi
View Study Details
RecruitingNCT05855200

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated T4N0 or Stage III (resectable), defective...

10 locations(Tucson, Los Angeles, New Haven)
811 participants
GlaxoSmithKline
View Study Details
RecruitingNCT05147220

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

10 locations(Phoenix, Scottsdale, Tucson)
800 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT05156281

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

10 locations(Phoenix, Hanford, Los Angeles)
800 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT05642611

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

This phase III trial compares the effect of 3 study approaches in preventing chemotherapy-induced peripheral neuropathy: 1) cryocompression, 2) continuous compression, and 3) low cyclic compression. T...

10 locations(Birmingham, Martinez, Atlanta)
777 participants
SWOG Cancer Research Network
View Study Details
RecruitingNCT03668041

National Adaptive Trial for PTSD Related Insomnia

Many Veterans with posttraumatic stress disorder (PTSD) have trouble sleeping or have frequent nightmares. So far, no medication has been approved for treatment of insomnia in PTSD. The purpose of thi...

10 locations(Birmingham, Tuscaloosa, Phoenix)
774 participants
VA Office of Research and Development
View Study Details
RecruitingNCT06709014

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the safety of buntanetap/Posiphen. The main q...

10 locations(Chandler, Phoenix, Scottsdale)
760 participants
Annovis Bio Inc.
View Study Details
RecruitingNCT06559306

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with placebo as an adjunctive therapy to an antidepressant i...

10 locations(Birmingham, Chandler, Tucson)
752 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT06807424

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis

The purpose of this study is to evaluate the efficacy of icotrokinra compared to placebo in biologic-experienced participants with active psoriatic arthritis (PsA) by assessing the reduction in signs ...

10 locations(Glendale, Mesa, Jonesboro)
750 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT06990867

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question th...

10 locations(Chicago, Baltimore, Tulsa)
740 participants
Corxel Pharmaceuticals
View Study Details
RecruitingNCT06216301

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

This study, known as LUNAR-2, aims to investigate the effectiveness and safety of using TTFields, delivered by the NovoTTF-200T device, concomitantly administered with pembrolizumab and platinum-based...

10 locations(Birmingham, Goodyear, Fullerton)
734 participants
NovoCure GmbH
View Study Details
RecruitingNCT05548283

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or I...

10 locations(Birmingham, Tucson, La Jolla)
730 participants
Chris Goss
View Study Details
RecruitingNCT06578247

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (I...

10 locations(Goodyear, Phoenix, Tucson)
700 participants
Daiichi Sankyo
View Study Details
RecruitingNCT01603316

Food: A Three-Arm Study Examining Food Insecurity Interventions

The investigators have found that many patients getting treatment for cancer have trouble getting enough to eat, or do not always have enough money for food. When a patient has these problems it can l...

10 locations(Brooklyn, Jamaica, New York)
668 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingNCT04138394

VItamin C in Thermal injuRY: The VICToRY Trial

This study aims to show that giving high dose, intravenous vitamin C in addition to standard care to burned critically ill patients will be associated with less organ dysfunction, improved survival an...

10 locations(Phoenix, Bridgeport, Washington D.C.)
666 participants
Clinical Evaluation Research Unit at Kingston General Hospital
View Study Details
RecruitingNCT04875702

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

The TRUST study is a randomized, controlled multicenter study to evaluate the management of gout by comparing two commonly used treatment strategies for gout (TTT vs TTASx) to determine the most benef...

7 locations(South Birmingham, Santa Monica, Boston)
650 participants
Massachusetts General Hospital
View Study Details
RecruitingNCT04108156

A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of the PDS with ranibizumab in participants with DME when treated every 24 weeks (Q24W) compared with intravitreal (IVT) ranibi...

10 locations(Mesa, Phoenix, Phoenix)
634 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT06417814

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

This study will assess the effect of Dato-DXd in combination with osimertinib or Dato-DXd monotherapy versus platinum-based doublet chemotherapy in terms of progression-free survival (PFS)....

10 locations(Fayetteville, Duarte, Fountain Valley)
630 participants
AstraZeneca
View Study Details
RecruitingNCT06091202

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims ...

4 locations(Minneapolis, Portland, Nashville)
608 participants
Oregon Health and Science University
View Study Details
RecruitingNCT05877963

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

The primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab as measured by T1 Gadolinium (Gd)-enhancing lesions and pharmacokinetics in participants with ...

10 locations(Birmingham, Cullman, Orange)
600 participants
TG Therapeutics, Inc.
View Study Details
RecruitingNCT06892548

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

This study aims to investigate the combination of BNT324, a B7-H3 antibody-drug conjugate (ADC) with BNT327, a programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor (VEGF) bispecifi...

9 locations(Beverly Hills, Hackensack, Fairfax)
594 participants
BioNTech SE
View Study Details
RecruitingNCT07063745

A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

The purpose of this study is to compare the clinical benefit of the combination of BMS-986504 (a selective MTA-cooperative inhibitor of PRMT5) plus pembrolizumab and chemotherapy versus placebo plus p...

10 locations(Anchorage, Phoenix, Tucson)
590 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT06563895

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that accumulates in different orga...

10 locations(La Jolla, Stanford, New Haven)
582 participants
Eidos Therapeutics, a BridgeBio company
View Study Details
RecruitingNCT06824181

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether the investigational pneumococcal conjugate vaccine PCV21 is safe and can help the body to develop germ-fi...

10 locations(Hollywood, Miami, Sioux City)
580 participants
Sanofi
View Study Details
RecruitingNCT05143177

A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

This is an adaptive Phase 2/3 multicenter, double-blind, placebo-controlled, randomized, parallel, 2 arm study to evaluate the efficacy and safety of DA-1229 compared to placebo in patients with calci...

10 locations(Phoenix, Los Angeles, Aurora)
580 participants
REDNVIA Co., Ltd.
View Study Details
RecruitingNCT04661358

Fenofibrate for Prevention of DR Worsening

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately s...

10 locations(Glendale, Huntington Beach, Loma Linda)
560 participants
Jaeb Center for Health Research
View Study Details
RecruitingNCT06866405

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous ...

10 locations(Birmingham, Birmingham, Birmingham)
550 participants
Pfizer
View Study Details
RecruitingNCT07196501

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

The primary objective of this study is to evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in delaying relapse of depressive symptoms (maintenance of effect) in pa...

4 locations(Melbourne, Miami Gardens, O'Fallon)
550 participants
Neurocrine Biosciences
View Study Details
RecruitingNCT06631287

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertio...

4 locations(San Francisco, Atlanta, Minneapolis)
550 participants
Wes Ely
View Study Details
RecruitingNCT06850922

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1...

10 locations(Phoenix, Phoenix, Phoenix)
546 participants
Genentech, Inc.
View Study Details
RecruitingNCT06878404

A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

The purpose of this study is to evaluate the efficacy of icotrokinra compared to placebo in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA....

10 locations(Jonesboro, DeBary, Plantation)
540 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT06693648

A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, 6-week trial of a formulation of AMZ001 once daily versus placebo once daily....

10 locations(Thousand Oaks, Hialeah, Longwood)
540 participants
Amzell
View Study Details
RecruitingNCT04961567

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active...

10 locations(Birmingham, Glendale, Huntington Beach)
540 participants
Biogen
View Study Details
RecruitingNCT04895241

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active...

10 locations(Homewood, Beverly Hills, Los Angeles)
540 participants
Biogen
View Study Details
RecruitingNCT04910685

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

This is a randomized, double-blind, placebo-controlled, Phase 2/3 study comparing the efficacy and safety of elenestinib (BLU-263) + symptom directed therapy (SDT) with placebo + SDT in participants w...

10 locations(Birmingham, Palo Alto, Boston)
534 participants
Blueprint Medicines Corporation
View Study Details
RecruitingNCT06018337

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-free survival (PFS) by blinded independent central ...

10 locations(Tucson, Fullerton, Los Angeles)
532 participants
DualityBio Inc.
View Study Details
RecruitingNCT06646276

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide to that of Atezolizumab...

10 locations(Daphne, Hot Springs, Fort Myers)
530 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT05552976

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2....

10 locations(Mobile, Cerritos, Irvine)
525 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT06847724

An Efficacy and Safety Study With Integrated Pharmacokinetics (PK) and Pharmacodynamic (PD) Assessment to Compare the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis (RMS)

The goal of this clinical trial is to learn if drug CYB704, a proposed biosimilar to Ocrevus, works to treat multiple sclerosis in the same way as the reference product Ocrevus(R). The main questions...

10 locations(Maitland, Ormond Beach, Banja Luka)
518 participants
Sandoz
View Study Details
RecruitingNCT04524871

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

This is a Phase Ib/II, open-label, multicenter, randomized umbrella study in participants with advanced liver cancers. The study is designed with the flexibility to open new treatment arms as new trea...

10 locations(Costa Mesa, Duarte, La Jolla)
518 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT04442022

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or Without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive hematopoetic stem ce...

10 locations(Chandler, Tucson, Cerritos)
501 participants
Karyopharm Therapeutics Inc
View Study Details
RecruitingNCT05438043

A Study of Daratumumab

The purpose of this study is to provide ongoing access to study treatments for participants with multiple myeloma or smoldering multiple myeloma benefiting from treatment in certain Janssen Research a...

10 locations(Miami, Atlanta, Ann Arbor)
500 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT06481891

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (HCM) treated with sotagliflozin as compar...

10 locations(Scottsdale, Los Angeles, Pomona)
500 participants
Lexicon Pharmaceuticals
View Study Details
RecruitingNCT06858111

Fertilo In Vitro Research Study and Trial

The goal of this clinical trial is to evaluate the safety and efficacy of using Fertilo for In vitro maturation (IVM) in participants 18-35 years of age. The main question it aims to answer is whether...

8 locations(Encino, Clearwater, Winter Park)
500 participants
Gameto, Inc.
View Study Details
RecruitingNCT06571383

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

The study is testing how well semaglutide can help adolescents with excess body weight to lose weight and to maintain weight loss. All participants in the study will receive semaglutide as a weekly in...

10 locations(Escondido, Orlando, Tallahassee)
500 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT06548542

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms i...

10 locations(Dothan, Mobile, Coronado)
500 participants
AbbVie
View Study Details
RecruitingNCT05766670

Intramedullary Calcium Sulfate Antibiotic Depot

The goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients...

10 locations(Los Angeles, Macon, Lexington)
497 participants
Wake Forest University Health Sciences
View Study Details
RecruitingNCT06152575

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer). This study is s...

10 locations(Mobile, Goodyear, Beverly Hills)
492 participants
Pfizer
View Study Details
RecruitingNCT05620407

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population....

10 locations(Searcy, La Jolla, La Mesa)
490 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT07003919

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy....

10 locations(Birmingham, Birmingham, Tucson)
480 participants
DBV Technologies
View Study Details
RecruitingNCT05531565

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with cutaneous lupus erythematosus (CLE). The study will focus on participants who have eithe...

10 locations(Anniston, Birmingham, Phoenix)
474 participants
Biogen
View Study Details
RecruitingNCT07076121

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

The purpose of this study is to assess the safety and efficacy of BMS-986504, a selective, MTA-cooperative PRMT5 inhibitor, in combination with Nab-paclitaxel/Gemcitabine (nab-p/gem) versus placebo in...

10 locations(Phoenix, Springdale, San Francisco)
470 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT06015737

A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus (CLE)....

10 locations(Glendale, Phoenix, Covina)
460 participants
AstraZeneca
View Study Details
RecruitingNCT06201676

Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients

The goal of this randomized clinical trial is to learn if the use of a low-dose nonsteroidal anti-inflammatory drug (NSAID), ketorolac, reduces the rate of chronic opioid use in orthopaedic polytrauma...

2 locations(Boston, Nashville)
458 participants
Massachusetts General Hospital
View Study Details
RecruitingNCT05703178

Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

The main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with stage I-III breast cancer, who have completed th...

2 locations(Chicago, Durham)
452 participants
Northwestern University
View Study Details
RecruitingNCT03926624

Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior induction regimens: Experimental arm: DFP-10917 14-day contin...

10 locations(Birmingham, Gilbert, Scottsdale)
450 participants
Delta-Fly Pharma, Inc.
View Study Details
RecruitingNCT05711394

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other sy...

10 locations(Huntsville, Little Rock, Little Rock)
450 participants
AbbVie
View Study Details
RecruitingNCT06388733

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

The goal of this Phase 3 clinical trial is to compare the efficacy of niraparib versus temozolomide (TMZ) in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma multiforme (GBM). T...

10 locations(Birmingham, Phoenix, La Jolla)
450 participants
Ivy Brain Tumor Center
View Study Details
RecruitingNCT06417775

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, o...

10 locations(Birmingham, Huntsville, Chandler)
450 participants
AbbVie
View Study Details
RecruitingNCT06088290

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

The primary objective of this phase III study is to evaluate whether the combination of lurbinectedin plus doxorubicin given as first line treatment for metastatic leiomyosarcoma (LMS) prolongs the pr...

10 locations(Phoenix, Beverly Hills, Los Angeles)
450 participants
PharmaMar
View Study Details
RecruitingNCT06153420

Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with predominant diarrhea (IBS-D) in adult patients. Th...

10 locations(Dothan, Huntsville, Phoenix)
450 participants
CinPhloro Pharma, LLC
View Study Details
RecruitingNCT06615479

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

The purpose of this study is to compare the efficacy and safety of arlo-cel (BMS-986393) versus standard regimens in adult participants with Relapsed or Refractory and Lenalidomide-exposed Multiple My...

10 locations(Birmingham, Los Angeles, Miami)
440 participants
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
View Study Details
RecruitingNCT06245408

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Primary Objective: To evaluate the effect of dazodalibep on patient-reported symptoms of SS in participants with moderate-to-severe symptom state Secondary Objectives: 1. To evaluate the effect of ...

10 locations(Chandler, Flagstaff, Gilbert)
435 participants
Amgen
View Study Details
RecruitingNCT05867251

Study of AVZO-021 in Patients With Advanced Solid Tumors

This study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-021 in patients...

10 locations(New Haven, Sarasota, Tampa)
430 participants
Avenzo Therapeutics, Inc.
View Study Details
RecruitingNCT07038343

Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

This study, the first clinical trial of AVZO-1418, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of AVZO-1418 when admi...

8 locations(Denver, Orlando, Sarasota)
430 participants
Avenzo Therapeutics, Inc.
View Study Details
RecruitingNCT05672576

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms. The main questions it aims to answer ar...

10 locations(Tucson, La Jolla, Northridge)
420 participants
Viatris Innovation GmbH
View Study Details
RecruitingNCT06810505

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to...

10 locations(Huntsville, Little Rock, Little Rock)
420 participants
AbbVie
View Study Details
RecruitingNCT05648500

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to severe symptoms. The main questions it aims to answer a...

10 locations(Fullerton, Huntington Park, Aurora)
420 participants
Viatris Innovation GmbH
View Study Details

Frequently Asked Questions

What clinical trials are available for Multiple Sclerosis?

There are currently 100 actively recruiting clinical trials for multiple sclerosis. These studies are testing new treatments, therapies, and interventions at research sites across 309 cities.

How do I join a Multiple Sclerosis clinical trial?

To join a multiple sclerosis clinical trial: 1) Browse the available studies above, 2) Click on a study that interests you, 3) Complete the eligibility form, and 4) A study coordinator will contact you.

Are clinical trials free for patients?

Yes, clinical trial participation is free. In most studies, the treatment, medical tests, and doctor visits related to the trial are provided at no cost. Some studies may also compensate for time and travel.

Can I leave a clinical trial if I change my mind?

Yes, participation in any clinical trial is completely voluntary. You can withdraw at any time, for any reason, without affecting your regular medical care.